APA (7th ed.) Citation

Tanimoto, K., Kato, K., Aoki, T., Yoshimoto, G., Choi, I., Kadowaki, M., . . . Akashi, K. (2021). CHOP Plus Sequential Mogamulizumab As First-Line Therapy for Untreated Adult T-Cell Leukemia-Lymphoma. Blood, 138(Supplement 1), 1393. https://doi.org/10.1182/blood-2021-151937

Chicago Style (17th ed.) Citation

Tanimoto, Kazuki, et al. "CHOP Plus Sequential Mogamulizumab As First-Line Therapy for Untreated Adult T-Cell Leukemia-Lymphoma." Blood 138, no. Supplement 1 (2021): 1393. https://doi.org/10.1182/blood-2021-151937.

MLA (9th ed.) Citation

Tanimoto, Kazuki, et al. "CHOP Plus Sequential Mogamulizumab As First-Line Therapy for Untreated Adult T-Cell Leukemia-Lymphoma." Blood, vol. 138, no. Supplement 1, 2021, p. 1393, https://doi.org/10.1182/blood-2021-151937.